Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.230
+0.110 (5.19%)
Feb 21, 2025, 4:00 PM EST - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $33.68 million as of February 21, 2025. Its market cap has decreased by -40.22% in one year.
Market Cap
33.68M
Enterprise Value
31.05M
1-Year Change
-40.22%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $33.68M, a decrease of -48.97%. That is a compound annual growth rate of -33.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 33.68M | 26.70% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |